Portfolio & Case Studies
Built products, research notes, and selective investments—structured for clarity.
GigHz is the hub. Some items below are products we built and operate. Others are research briefs or positions we have taken over time. Nothing here is financial advice or a solicitation.
A public real-estate data platform that puts city, county, ZIP-code and neighborhood market signals side by side so investors can screen markets before they screen deals.
A browser-based reporting tool that turns dictated findings into a structured Technique / Findings / Impression draft and flags contradictions before sign-off.
A physician directory built on U.S. provider registry data, where doctors claim and correct their own profile for free.
A vascular and interventional radiology reference library with board-review Q&A, plus a routed connection between attorneys and board-certified IR experts.
Enter a CPT code, payer and indication and get a payer-matched documentation checklist before submission — or upload a denial letter and get a structured appeal.
A behavioral-finance self-assessment that profiles how you actually handle money across risk behavior, impulse bias, planning style and consistency.
A structured exercise database that grades which movements have research support for a specific goal and which are mostly marketing.
Upload an MP3 or WAV and get hook-window timestamps, BPM and key, an energy map, and three beat-matched loop-ready cuts for short-form.
A rule-based clinical decision support engine covering 413 conditions across 40+ specialties, delivered as a REST API plus a drop-in OpenEMR module.
CenterIQ
LiveFinancial modeling for ambulatory surgery and imaging centers built on the CMS hospital price transparency dataset, with named hospital-and-insurer rate citations per CPT per state.
A directory of medical AI tools organized the way clinicians think — by specialty, workflow, EHR integration and HIPAA posture — with every entry verified before it is listed.
A browser tool for building, saving and printing structured procedure setup cards and room layouts, with everything stored on the device.
Point a phone at the PACS monitor, outline the lesion, and get volume, probe count, trajectory validation and a coverage heat map with margin analysis.
A deliberately conservative PE triage calculator that emits an ESC-style risk label and one of four recommendation cards, with explicit escalation triggers instead of gestalt.
Turns de-identified EMR exports into referral network intelligence: who is sending volume, where it is leaking out, and which relationships are drifting.
Turns the SIR 2019 anticoagulation consensus into a bedside workflow for hold planning, day-of clearance and restart timing.
A browser-based planning tool for physicians pairing a student-loan decision engine with a rule-based tax strategy screener and a CPA prep packet.
An evidence-and-risk brief on teleradiology: the operational leverage buyers are actually purchasing, and the licensing and QA constraints that decide whether it holds.
Graphene Market Landscape 2025
ResearchedA brief that reframes graphene as a specification and manufacturing-consistency problem rather than a product story.
A diligence framework for deep tech — readiness, unit economics, validation path, time horizon — built on the observation that translation, not science, is where projects die.
A workflow-first brief on AI in radiology: where it earns its keep today, how to evaluate a tool, and what actually breaks adoption.
A category-level brief on biopsy tract closure: what evidence matters, what it costs in procedure time, and what decides whether clinicians reach for it.
A category-level brief on home tele-rehab: the adherence gap it targets, the payer pathway that usually decides it, and where operations break.
A skeptical brief on de-extinction: why the headline animal is not the thesis, and what the underlying gene-editing platform would have to prove.
A diligence scaffold for two proof-heavy markets — anti-counterfeiting and carbon capture — where procurement, not narrative, decides the outcome.
A diligence framework for glioblastoma programs: mechanism, CNS exposure, preclinical quality, and the clinical path.
A framework for testing graphene-at-scale claims: what spec is guaranteed, how QC is measured, and whether any use case pays for it.
Written and reviewed by Pouyan Golshani, MD, Interventional Radiologist — Last updated April 8, 2026
Part of the GigHz library: systems doctors were never taught.